|Articles|August 1, 2001
- Pharmaceutical Technology-08-01-2001
- Volume 2001 Supplement
- Issue 2
Successfully Outsourcing Formulation DevelopmentConsiderations for Emerging Biopharmaceutical Companies
Author(s)Shabbir T. Anik, PhD, Colin M. Minchom, PhD
Successfully taking a new chemical entity from proof-of-concept to commercialization requires the biopharmaceutical company to carefully evaluate a contract services provider's formulation department and ability to become a fully integrated supplier.
Advertisement
Articles in this issue
over 24 years ago
Creating a Successful Partnership with a Contract Manufacturerover 24 years ago
Outsourcing Outlookover 24 years ago
Creative Solutions in Client-CRO Relationshipsover 24 years ago
Third-Party Technology Transferover 24 years ago
The Squeeze in Contract Manufacturingover 24 years ago
Stakes Rise for Blown Batchesover 24 years ago
Partnerships in Drug DiscoveryNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FAQ: Key Innovations in Drug Delivery and Formulation in 2025
2
Regulatory Expectations for Evaluating GMP Facilities and Equipment
3
Optimizing Pharmaceutical Manufacturing Efficiency
4
Trends and Challenges Impacting Highly Potent API Development
5
